Dirk P. Dittmer · Susan E. Krown
Editors

2010

More than 25 years into the AIDS pandemic, cancers that develop in individuals infected with human immunodeficiency virus (HIV) continue to challenge epidemiologists, virologists, molecular biologists, immunologists, and clinicians treating affected patients in both developed and resource-limited environments.